Page last updated: 2024-12-10

riopan

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3086011
MeSH IDM0066635

Synonyms (19)

Synonym
riopan plus
magaldrate
aluminum magnesium hydroxide sulfate, hydrate
pentaaluminium-decamagnesium-hentriacontahydroxid-bis(sufat)-n-wasser
ay 5710
unii-6v88e24n5t
riopan
dynese
agastrin
magaldratum
malumix
bemolan
magaldrato
magaldratum [latin]
magaldrato [spanish]
aluminum magnesium hydroxide sulfate (al5mg10(oh)31(so4)2.xh2o)
magaldrate [usan:usp:inn:ban]
Q419991
aluminum;magnesium;hydroxide;sulfate

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" However, we recommend the use of antacids with an aluminium absorption rate as low as possible."( Serum aluminium levels of intensive care patients treated with two different antacids for prevention of stress ulceration.
Böhrer, H; Fleischer, F; Jürs, G; Krier, C; Rauch, H; Wilhelm, M, 1989
)
0.28
" The effect of 20 ml of Riopan, given 1 h after oral administration of Indocid capsules (MSD, 25 mg) to fed dogs, on the bioavailability of indomethacin was also studied."( Effect of antacid magaldrate oral suspension on in-vitro and in-vivo availability of indomethacin in dogs.
al-Gohary, OM; Hosny, EA, 1997
)
0.6

Dosage Studied

ExcerptRelevanceReference
" By this the necessary daily dosage could be reduced essentially."( [Lattice structure antacids and antacid mixtures].
Miederer, SE; Schmidt, C, 1987
)
0.27
" Considering the short-lasting effect on acid neutralization induced by the antacid dosage used in this study and the inability of oxmetidine treatment to influence volume densities and secretory activities of antral G- and D-cells it is concluded that mechanisms other than a change of antral pH may account for the results obtained during antacid treatment."( Effect of antacid and H2-receptor blocker treatment on gastric endocrine cells.
Arnold, R; Garbe, I; Koop, H; Mönnikes, H; Schwarting, H, 1984
)
0.27
" These profiles are misleading because the uniformity of dosage units was tested before the dissolution studies."( Determination of norfloxacin by fluorescence in the presence of different antacids: quantification of analytical interferences.
Bernabé, I; Córdoba-Borrego, M; Córdoba-Díaz, D; Córdoba-Díaz, M, 1996
)
0.29
" The tablets complied with the requirements of the acid neutralizing capacity, uniformity of dosage units, disintegration and dissolution tests (USP XXIII) for buffered aspirin tablets."( Formulation of aspirin-magaldrate double-layer tablets: in vitro evaluation and cytoprotective activity in rats.
al Gohary, OM; el Din, K; el Tahir, H,
)
0.13
"A comparison of the antacid efficacy of magaldrate powder and its dosage forms on an equal weight basis by an in vitro technique revealed that: suspensions > chew tablets > powder."( In vitro evaluation of magaldrate antacid efficacy in the presence of some drugs and its effect on their dissolution rates: Part I.
al Gohary, OM, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (51)

TimeframeStudies, This Drug (%)All Drugs %
pre-199028 (54.90)18.7374
1990's15 (29.41)18.2507
2000's6 (11.76)29.6817
2010's1 (1.96)24.3611
2020's1 (1.96)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 90.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index90.29 (24.57)
Research Supply Index4.22 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index181.66 (26.88)
Search Engine Supply Index2.28 (0.95)

This Compound (90.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials12 (21.82%)5.53%
Reviews3 (5.45%)6.00%
Case Studies2 (3.64%)4.05%
Observational0 (0.00%)0.25%
Other38 (69.09%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]